IP Library Assignment 026166/0713
Patent Assignment
Reel/Frame 026166/0713

Assignment of Assignor's Interest

Recorded: 2011-04-21 Pages: 5
Assignors
ZHANG, XIAOKUI
Executed: 2010-09-08
VOSKINARIAN-BERSE, VANESSA
Executed: 2010-08-19
KANG, LIN
Executed: 2010-08-19
PADLIYA, NEERAV DILIP
Executed: 2010-08-18
PAL, AJAI
Executed: 2010-08-18
ZEITLIN, ANDREW
Executed: 2010-08-19
Assignee
ANTHROGENESIS CORPORATION
7 POWDER HORN DRIVE, WARREN, NEW JERSEY, 07059
Covered Property (1)
Tumor Suppression Using Human Placental Perfusate and Human Placenta-Derived Intermediate Natural Killer Cells
Patent: 8,263,065 →
Application: 12/240,956 →
Publication: US 2009/0252710
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 21, 2011
From: HARIRI, ROBERT J.
To: ANTHROGENESIS CORPORATION
Reel/Frame 026166/0815 →
Assignment of Assignor's Interest Apr 21, 2011
From: HEIDARAN, MOHAMMAD A.
To: ANTHROGENESIS CORPORATION
Reel/Frame 026166/0820 →
Merger Nov 8, 2017
From: ANTHROGENESIS CORPORATION
To: CLARITY ACQUISITION II LLC
Reel/Frame 044413/0680 →
Assignment of Assignor's Interest Nov 9, 2017
From: CLARITY ACQUISITION II LLC
To: CELULARITY, INC.
Reel/Frame 044780/0261 →